Know Cancer

forgot password

A Phase II, Open Label Trial of Ixabepilone Plus Cetuximab as First Line Therapy for Metastatic Pancreatic Cancer

Phase 2
18 Years
Not Enrolling
Metastatic Pancreatic Cancer

Thank you

Trial Information

A Phase II, Open Label Trial of Ixabepilone Plus Cetuximab as First Line Therapy for Metastatic Pancreatic Cancer

Inclusion Criteria:

- Histologic or cytologic diagnosis of pancreatic adenocarcinoma (locally advanced
disease that is not surgically resectable, or distant metastatic disease)

- Participants must have measurable disease as per Response Evaluation Criteria In
Solid Tumors (RECIST) guidelines

- Participants must not have received prior chemotherapy, immunotherapy or
chemoradiotherapy for advanced pancreas cancer

- Karnofsky performance status (KPS) of 70-100

- Adequate hematologic, hepatic and renal function

Type of Study:


Study Design:

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

Percentage of Participants Surviving at 6 Months

Outcome Description:

The percentage of participants surviving at 6 months was defined as the number of treated participants who had not died prior to 6 months from the date of their first dose divided by the total number of treated participants.

Outcome Time Frame:

From time of first dose of study drug through 6 months

Safety Issue:


Principal Investigator

Bristol-Myers Squibb

Investigator Role:

Study Director

Investigator Affiliation:

Bristol-Myers Squibb


United States: Food and Drug Administration

Study ID:




Start Date:

January 2007

Completion Date:

June 2009

Related Keywords:

  • Metastatic Pancreatic Cancer
  • Pancreatic Neoplasms



University of Michigan Ann Arbor, Michigan  48109-0624
Mayo Clinic Jacksonville Jacksonville, Florida  32224
Cancer Centers of the Carolinas Greenville, South Carolina  29605
Ellis Fischel Cancer Center Columbia, Missouri  65203
Seattle Cancer Care Alliance Seattle, Washington  98109
Wayne State University Detroit, Michigan  48202
University of Miami Miami, Florida  33136
West Virginia University Morgantown, West Virginia  26506
Georgetn Univ Lombardi Can Ctr Washington, District of Columbia  20007